News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer – Even Better Ones Are Yet to Come
Yakup Ergün/obdh.com.tr
Jun 19, 2025, 11:53

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer – Even Better Ones Are Yet to Come

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared an article on X:

“The next generation of immunotherapies for lung cancers
Although there are many drugs currently in development, my current favorites are ivonescimab (PD-1 × VEGF) and tarlatamab (DLL3 × CD3).
Even better ones are yet to come.”
ivonescimab

Title: The next generation of immunotherapies for lung cancers

Authors: Shen Zhao, Hongyun Zhao, Weiwei Yang, Li Zhang

Read Full Article.

Yakup Ergün: Ivonescimab (PD-1 × VEGF) and Tarlatamab (DLL3 × CD3) are My Favorite Drugs For Lung Cancer - Even Better Ones Are Yet to Come

More posts featuring Yakup Ergün.

cancer Hongyun Zhao Li Zhang lung cancers OncoDaily Oncology Shen Zhao Weiwei Yang
Special Coverage
Blog
Jul 27, 2025, 18:45
Thanks for Showing Up, Sharing Your Work, and Believing in Collaboration at KCRS25 - KidneyCAN
Blog
Jul 27, 2025, 18:34
Hamza Hashmi: Sharing Ideas, Research, and Debates on Myeloma at the MM Sparks Event in Merida
Blog
Jul 27, 2025, 18:26
Cathy Eng: Always a Pleasure to Listen to Kristen Ciombor Give a Lecture about Immunotherapy in MSI-S CRC
Blog
Jul 27, 2025, 17:40
Aladina Foundation's Psychooncologists Offer a Consultation Outside the Hospital for Free
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals